Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:40 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer
NCT00226954 · Stanford University · PHASE2 · terminated · last registry update 2020-03-18 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
No reason was published
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | The registry record gives no reason | – | Registry record, Stanford University |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against FDPS within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2021-03-03Phase 3 first posted: Karen Klahr Miller, MD, Romosozumab Prefilled Syringe + Placebo (NCT04779216)
- 2021-01-22Results posted on the registry: Massachusetts General Hospital, denosumab + teriparatide (NCT02176382)
- 2021-01-22Results posted on the registry: Wake Forest University Health Sciences, Risedronate Sodium 150 MG (NCT03411902)
- 2021-01-14Results posted on the registry: Aarhus University Hospital, Zoledronic Acid (NCT03087851)
- 2021-01-12Phase 3 first posted: Sherief Abd-Elsalam, nonselective beta blocker + cardio-selective beta blocker group (NCT04704947)
- 2020-12-28Results posted on the registry: M.D. Anderson Cancer Center, Actonel (Risedronate) (NCT00452439)
- 2020-12-11Results posted on the registry: Radius Health, Inc., Alendronate (NCT01657162)
- 2020-12-08Also stopped (terminated): Northwestern University, calcium gluconate + zoledronic acid (NCT00058188)
- 2020-12-01Results posted on the registry: Ondokuz Mayıs University, Bisphosphonate therapy (NCT04149405)
- 2020-11-19Results posted on the registry: Northwestern University, calcium gluconate + zoledronic acid (NCT00058188)
- 2020-10-22Also stopped (terminated): University of Wisconsin, Madison, Alendronate (NCT02781805)
- 2020-08-21Also stopped (terminated): Johns Hopkins University, Teriparatide + Alendronate (NCT01656629)
- 2020-07-17Results posted on the registry: Massachusetts General Hospital, rhIGF-1 + Risedronate (NCT01406444)
- 2020-05-12Results posted on the registry: University of California, San Francisco, Zoledronic Acid (NCT00295867)
- 2020-04-28Results posted on the registry: City of Hope Medical Center, zoledronic acid (NCT01409811)
- 2020-03-24Results posted on the registry: Gynecologic Oncology Group, Zoledronic Acid (NCT00305695)
- 2020-03-10Phase 3 first posted: Vestre Viken Hospital Trust, Zoledronic Acid + Saline 0.9% (NCT04303026)
- 2019-12-12Also stopped (terminated): Hamad Medical Corporation, Denosumab 60 MG/ML Prefilled Syringe + Zoledronic Acid 5Mg/Bag 100Ml Inj (NCT03040765)
- 2019-11-25Also stopped (terminated): University of Wisconsin, Madison, IL2 + Zoledronic acid (NCT00582790)
- 2019-11-20Phase 3 first posted: Ain Shams University, Denosumab 60 mg/ml [Prolia] + Alendronate 70Mg Tab (NCT04169698)
- 2019-11-18Results posted on the registry: University of Louisville, Simvastatin and zoledronic acid (NCT01772719)
- 2019-11-18Also stopped (terminated): University of Louisville, Simvastatin and zoledronic acid (NCT01772719)
- 2019-09-20Results posted on the registry: Novartis Pharmaceuticals, Zoledronic acid (NCT01197300)
- 2019-09-16Also stopped (withdrawn): Novartis Pharmaceuticals, Zoledronic acid 5mg (NCT02333344)
- 2019-09-13Also stopped (terminated): Oslo University Hospital, Zoledronic Acid Injectable Product + Placebo (NCT03576599)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision